School of Pharmacy

Remembering Robert D. Gibson

Tue Aug 21, 2018
Gibson

Robert D. Gibson, PharmD ’58, wearing his Remington medal at an event in 2010

A beloved educator and alumnus of the UCSF School of Pharmacy, Robert D. Gibson, PharmD ’58, died on July 19 at the age of 93. Gibson had an illustrious career over five decades at UCSF and was a strong national leader for diversity in the pharmacy profession.

The dean advocates for medication lists and pharmacist engagement in patient care

Tue Aug 21, 2018
Guglielmo
Elisabeth Fall

School of Pharmacy Dean B. Joseph Guglielmo, PharmD

Medical errors are the third leading cause of death in the U.S., trailing cancer and heart disease. Many of those errors can be traced to issues with medications.

A celebration of Robert D. Gibson’s life

Fri Aug 17, 2018
Gibson

Robert D. Gibson, PharmD ’58, at an award dinner in 1991

Robert D. Gibson, PharmD ’58, had an illustrious career over five decades at the UCSF School of Pharmacy and was a strong, national leader for diversity in the pharmacy profession. Join the School in a celebration of his life.

B. Joseph Guglielmo: How pharmacists can help solve medication errors

Thu Aug 16, 2018

School welcomes incoming PharmD class with bold new curriculum

Wed Aug 8, 2018
PharmD students arrive at UCSF for the first day of classes.
Elisabeth Fall

New PharmD students, including Asher Jeong (right), arrive at the UCSF Parnassus campus for the first day of their pharmacy education

A new class of UCSF doctor of pharmacy (PharmD) students came together on July 25 at the Parnassus campus to inaugurate a new curriculum built on critical thinking, problem solving, and an inquiry habit of mind.

Stopping cancer in its tracks

Thu Jul 19, 2018
Cancerous breast tissue, with normal connective tissue (pink) and cancer cells (blue).
Cecil Fox, National Cancer Institute

Cancerous breast tissue, with normal connective tissue (pink) and cancer cells (blue).

Cancer, fundamentally, is a problem of too much growth. For decades, health care providers have tried and failed to slow tumor growth using drugs that interfere with a particular signaling pathway, called PI3K, which is known to operate in proliferating cancer cells.

Creating the tools to build a Human Cell Atlas

Wed Jul 18, 2018
cells under microscope.
Natalie Prigozhina

Human hair follicle cells, cytoskeletons in green and nuclei in blue.

If it’s hard to take an accurate census of the 325 million people living in the US, it’s even more daunting to survey the 37.2 trillion or so cells that make up the human body. The brain alone, for instance, contains nearly 90 billion neurons, which can be classified into over a thousand distinct...

More California kids are having pot-related health scares, poison control officials warn

Tue Jul 17, 2018

Update from the Dean – July 2018

Mon Jul 16, 2018
Health at the molecular level: Decoding cellular signals, A trigger for tissue repair, Seeding tomorrow’s science. The future of custom care: Tracking cancer drug resistance, Treating malaria and tuberculosis, Quantitative Biosciences Institute’s culture of inclusivity, The genetics of asthma....

Drilling down to the details of opioid signaling

Wed Jul 11, 2018
Study captures an opioid drug binding to a µ-opioid receptor
Antoine Koehl (Manglik lab)

Study captures an opioid drug (orange) binding to a µ-opioid receptor (green) and activating various signaling proteins (cyan, purple, gold), which produce the effects of opioid drugs, like pain relief and addiction.

Despite using opioids for centuries for pain management, we still don’t have a complete understanding of how drugs like morphine and oxycodone actually work. And that’s a problem for patients, who must weather side effects that can range from nausea and constipation to cognitive impairment,...

Pages